Bayer AG won the backing of European Union regulators for its cardiology drug as the German company fights to offset the ...

Trial explores potential of therapy in treating multiple cancer types Bayer has begun a phase 1 clinical trial for BAY3498264 ...

Leverkusen: Bayer has announced that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start ...

Bayer is breaking into the irritable bowel syndrome (IBS) therapy market with the acquisition of HiDoc Technologies, which ...

After the recent drop, Bayer is so cheap now that all negativity seems to be priced in. Find out why BAYRY stock is a Buy.

Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...

Bayer announced that the company plans to acquire HiDoc Technologies ... In addition to pharmacological therapy, such as treatment with plant-based pharmaceuticals such as Iberogast, the current ...

Bayer initiates phase I study with SOS1 inhibitor, BAY3498264 in patients with advanced KRAS-mutated tumours: Berlin Saturday, December 14, 2024, 13:00 Hrs [IST] Bayer announced i ...

Epigenic, Immunocan have officially moved into Bayer Co.Lab, and AccurEdit Therapeutics will join early next month. Photo: ...

FRANKFURT, Nov 19 (Reuters) - Bayer (BAYGn.DE), opens new tab on Tuesday struck a collaboration deal with U.S. biotech firm Cytokinetics (CYTK.O), opens new tab to acquire certain rights in Japan ...

Earlier this year, Bayer Pharmaceuticals announced a reshaping and streamlining of its leadership team as it embarked on its next phase of growth. With that, Guth was tapped to also serve as COO ...

Victoria's Supreme Court has ruled against more than 1,400 Australian women who launched a class action against the maker of ...